NIDA's Medication Development Program--1989.
Schuster
C R
CR
National Institute on Drug Abuse, Rockville, Maryland 20857.
Snyder
M
M
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D001921:Brain / Q000187:drug effects; D003042:Cocaine; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D005260:Female; D006556:Heroin Dependence / Q000534:rehabilitation; D006801:Humans; D007231:Infant, Newborn; D008691:Methadone / Q000627:therapeutic use; D008692:Methadyl Acetate / Q000627:therapeutic use; D009271:Naltrexone / Q000627:therapeutic use; D011247:Pregnancy; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012109:Research Support as Topic / Q000331:legislation & jurisprudence; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000534:rehabilitation; D019966:Substance-Related Disorders / Q000534:rehabilitation*
D011619:Psychotropic Drugs; D009271:Naltrexone; D003042:Cocaine; D008692:Methadyl Acetate; D008691:Methadone